Marsh & McLennan (MMC) Stock Can Q3 Earnings Keep Margin Gains On Track

Marsh & McLennan shares barely flinched after Q3 2026 earnings, edging up about 1% to around US$188, even as the headline numbers pointed to a stronger story than the price move suggests. The firm posted Q3 revenue of US$6.9b and adjusted earnings per share of US$2.03, both solid for a global insurance broker and consulting heavyweight.

Over the past month the stock has crept higher, yet the real focus now shifts to the longer runway. Multi year earnings forecasts, a rich but mixed valuation profile and the margin trend will matter far more than today’s modest price reaction.

Like the stability in Marsh & McLennan Companies’ earnings but unsure whether a global broker at around US$188 leaves enough upside for your next move? Check out our list of solid balance sheet and fundamentals stocks (25 results).

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs Q3 2025): US$6,863m vs. US$6,351m (up about 8%)
• Net Income (Excl. Extra Items, Q3 2026 vs Q3 2025): US$808m vs. US$747m (up about 8%)
• Basic EPS (Q3 2026 vs Q3 2025): US$1.70 vs. US$1.52 (up about 12%)
• Adjusted Operating Margin (Q3 2026): 22.7% (management highlighted continued margin expansion compared with the prior year)

Ask Charlie what Marsh & McLennan’s AI push means for growth.

Marsh & McLennan’s AI and Efficiency Story Under Review

The bullish pitch is that Marsh & McLennan can turn heavy spending on technology and reengineering into structurally leaner operations and higher profitability.

"Reengineering of mid and back office processes through the expanded partnership with AWS, together with the Thrive efficiency program that is targeted to deliver US$400 million of savings for about US$500 million of charges, can lower the cost base and support continued margin expansion and earnings resilience even as insurance pricing pressure weighs on revenue growth."

Q3 adjusted operating margin of 22.7% and management’s reaffirmed guidance for another year of margin expansion suggest early progress. Thrive has now been upsized to US$600m of targeted savings, although the higher cost to achieve means execution still has to stay tight.

Pricing Pressure And Legal Risk For Marsh & McLennan

The bear story argues that softer insurance cycles and legal exposures could quietly erode the economics that AI and cost cuts are meant to protect.

"Persistent declines in property and reinsurance pricing, including recent risk adjusted rate reductions in key markets and lower primary commercial insurance rates, could continue to weigh on Marsh & McLennan Companies' broking commissions and slow revenue growth. This would pressure operating margins and earnings if cost savings and volume gains do not offset the drag."

Reinsurance revenue in Q3 declined 6% reported and underlying, and management flagged pricing headwinds likely to persist into the January renewal season. At the same time, Marsh spent US$30m in a quarter on litigation. Margin expansion in Q3 shows the pressure is being absorbed for now, but the strain is visible in the mix.

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.

Hunt Quiet Disconnects In Plain Sight

Marsh & McLennan Companies just reminded investors that earnings momentum and share price moves do not always line up cleanly. The real opportunity is spotting stocks that could be undervalued before the market closes the gap.

• Company 1 - 34% below our estimate - targets rising data center demand by expanding high horsepower engine capacity.
• Company 2 - 39% below our estimate - expands local payment rails as merchants route more emerging market transaction volume through its platform.
• Company 3 - 46% below our estimate - integrates a major bank merger to extend relationship teams and specialty lending platforms.

That is three of the list. See the full list of 33 companies trading below our fair value estimates →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com